Clinical Trial Update: Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating intraglandular injection of adipose-derived mesenchymal stem cells to treat xerostomia in Sjögren's syndrome; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Adipose-derived mesenchymal stem cells

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Sjorgren's Syndrome | Phase 1, Phase 2 | Status: RECRUITING